• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $CLF

    Cleveland-Cliffs Inc.

    Subscribe to $CLF
    $CLF
    Metal Mining
    Basic Materials

    Cleveland-Cliffs Inc. operates as a flat-rolled steel producer in North America. It also manufactures iron ore pellets. The company is vertically integrated from mined raw materials and direct reduced iron to primary steelmaking and downstream finishing, stamping, tooling, and tubing. It serves a range of markets through offering of flat-rolled steel products and supplies steel to the automotive industry. The company was formerly known as Cliffs Natural Resources Inc. and changed its name to Cleveland-Cliffs Inc. in August 2017. Cleveland-Cliffs Inc. was founded in 1847 and is headquartered in Cleveland, Ohio.

    IPO Year:

    Exchange: NYSE

    Website: clevelandcliffs.com

    Recent Analyst Ratings for Cleveland-Cliffs Inc.

    DatePrice TargetRatingAnalyst
    5/29/2025$6.00Buy → Hold
    Jefferies
    12/2/2024$16.00Buy
    Goldman
    8/27/2024$16.50Neutral → Buy
    Seaport Research Partners
    6/11/2024$23.00 → $17.00Overweight → Neutral
    JP Morgan
    5/20/2024$22.00Buy
    Jefferies
    4/9/2024$18.00Peer Perform → Underperform
    Wolfe Research
    3/13/2024$22.00Buy → Neutral
    Citigroup
    2/28/2024$16.50Neutral → Underperform
    Exane BNP Paribas
    2/15/2024$21.50 → $20.00Overweight → Equal-Weight
    Morgan Stanley
    2/9/2024$24.00Overweight
    JP Morgan
    See more ratings